uum: “953(67- asso— 4m- -9F38- mmaREceoz7
TCGA- pn- AACN- o1A- PR dacted

illllllllIlmlll:IIM|llllIIII“ IIIIIIIIIIlIIIIIIIR memIIIIII

 

CLINICAL DIAGNOSIS: HCC
Specimen: Liver
Gross Photo 1 1

GROSS:
Specimen:
Liver: 14.0 X 9.0 X 6.0 cm, unfixed
Tumor location: segment 6
Tumor number: one
Tumor size: 3.5 x 2.8 X 2.5 cm 102) (3..
Satellite nodule: no
Gross type (aMuwa-ZLI Jme; :QQQELQZSEAF $1573
HCC: expanding nodular _, . . i. 3
Tumor necrosis: less than 5 % Um i MW4 C 529(1)
Hemorrhage/peliosis: no i IQ '3 5‘); QI/L/
Portal vein invasion: no
Bile duct invasion: no
Satery margin: 1.8 cm

Gross photo present.

Blocks

”Fl-4, tumor and surrounding parenchyme of liver x 4
L, nontumorous liver parenchyme x 1

RM, resection margin of liver x 1

MICROSCOPIC:
Hepatocellular carcinoma, with cholangiocytic differentiation
Differentiation _ ' Haj—g; Z CAOIW‘OW MW .
The worst differentiation Ill
The major differentiation III
Histologic type: trabecular
Cell type: hepatic
Other tumor: no
Fibrous capsule formation: no
Capsular infiltration: no
Septum formation: no
Surgical resection margin invasion: no
Serosal invasion: no
Portal vein invasion: no
Bile duct invasion: no
Hepatic vein invasion: no
Hepatic artery invasion: no
Microvessel invasion: no

Intrahepatic metastasis: no
Multicentric occurrence: no

Nonrtumor liver pathology
Chronic hepatitis: yes
Etiology: HBV
Grade, lobular: I
Grade, portoperiportal: ll
Stage (fibrosis): I
Cirrhosis: no
Dysplastic nodule: no
Ductal epithelial dysplasia: no
Other liver diseases:
Fatty change: 60 %

SPECIAL STAIN: Mucicarmine (—)

IMMUNOHISTOCHEMISTRY:
CK7 (+, focal), CK (+ ), CK19 (+, focal), AFP (-), Hepatocyte (+)

NOT reported. Gross:

Disc material, ectomy, degenerated fibrocartilagenous tissue

Liver, ectomy, hepatocellular carcinoma, chronic hepatitis, steatosis
T56000, P10, M81703, MD0522, M50080

DIAGNOSIS:
Liver, segment 6, right posterior sectionectomy:
Hepatocellular carcinoma, poorly differentiated,
with cholangiocytic differentiation
Chronic hepatitis, associated HBV
Steatosis, moderate

NOTE:
(CK7, CK, CK19, APP, Hepatocyte) -

(mucicarmine)

Suggestion :

Crash

 

 

Diuguosls Discrepancy

 

 

 

 

0k ‘40 PrirnuvTumor Sine I“

 

 

 

 

 

 

HIPAA Discrepancy

 

 

Prior Malimanw Him
m ‘ Dual/Svnnhmnous
P an I: kink):
Reviewer Initials

 

 

 

